Lamictal 5mg dispersible tablets

Riik: Suurbritannia

keel: inglise

Allikas: MHRA (Medicines & Healthcare Products Regulatory Agency)

Toimeaine:

Lamotrigine

Saadav alates:

CST Pharma Ltd

ATC kood:

N03AX09

INN (Rahvusvaheline Nimetus):

Lamotrigine

Annus:

5mg

Ravimvorm:

Dispersible tablet

Manustamisviis:

Oral

Klass:

No Controlled Drug Status

Retsepti tüüp:

Valid as a prescribable product

Toote kokkuvõte:

BNF: 04080100; GTIN: 5055946805887 05055946807881

Infovoldik

Page 1 of 2
PACKAGE LEAFLET: INFORMATION FOR THE USER
LAMICTAL
® 25MG
DISPERSIBLE/CHEWABLE TABLETS
(lamotrigine)
Lamictal Dispersible/Chewable Tablets are available in the
following strengths: 2mg, 5mg, 25mg & 100mg. This leaflet
only applies to the 25mg Dispersible/Chewable Tablets which
will be referred to as Lamictal Dispersible/Chewable Tablets
throughout this leaflet.
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU
START TAKING THIS MEDICINE
BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.

Keep this leaflet. You may need to read it again.

If you have any further questions, ask your doctor or
pharmacist.

This medicine has been prescribed for you only. Do not
pass it on to others. It may harm them, even if their
signs of illness are the same as yours.

If you get any of the side effects, talk to your doctor or
pharmacist. This includes any possible side effects not
listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
1.
What Lamictal Dispersible/Chewable Tablets are and
what they are used for
2.
What you need to know before you take Lamictal
Dispersible/Chewable Tablets
3.
How to take Lamictal Dispersible/Chewable Tablets
4.
Possible side effects
5.
How to store Lamictal Dispersible/Chewable Tablets
6.
Contents of the pack and other information
1.
WHAT LAMICTAL DISPERSIBLE/CHEWABLE
TABLETS ARE AND WHAT THEY ARE USED FOR
Lamictal Dispersible/Chewable Tablets belong to a group of
medicines called _anti-epileptics_. They are used to treat two
conditions - EPILEPSY and BIPOLAR DISORDER.
LAMICTAL DISPERSIBLE/CHEWABLE TABLETS TREAT
EPILEPSY by blocking the signals in the brain that trigger
epileptic seizures (fits)

For adults and children aged 13 years and over, Lamictal
Dispersible/Chewable Tablets can be used on their own
or with other medicines, to treat epilepsy. Lamictal
Dispersible/Chewable Tablets can also be used with
other medicines to treat the seizures that occur with a
condition called Lennox-Gastaut syndrome.

For children aged between 2 and 12 years, Lamictal
Dispersibl

Toote omadused

PRODUCT SUMMARY
1.
NAME OF THE MEDICINAL PRODUCT
Not applicable
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Not applicable
3.
PHARMACEUTICAL FORM
Not applicable
4.
CLINICAL PARTICULARS
4.1.
THERAPEUTIC INDICATIONS
Not applicable
4.2.
POSOLOGY AND METHOD OF ADMINISTRATION
Not applicable
4.3.
CONTRAINDICATIONS
Not applicable
4.4.
SPECIAL WARNINGS AND PRECAUTIONS FOR USE
Not applicable
4.5.
INTERACTIONS WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF
INTERACTION
Not applicable
4.6.
PREGNANCY AND LACTATION
Not applicable
4.7.
EFFECTS ON ABILITY TO DRIVE AND USE MACHINES
Not applicable
4.8.
UNDESIRABLE EFFECTS
Not applicable
4.9.
OVERDOSE
Not applicable
5.
PHARMACOLOGICAL PROPERTIES
5.1.
PHARMACODYNAMIC PROPERTIES
Not applicable
5.2.
PHARMACOKINETIC PROPERTIES
Not applicable
5.3.
PRECLINICAL SAFETY DATA
Not applicable
6.
PHARMACEUTICAL PARTICULARS
6.1.
LIST OF EXCIPIENTS
Not applicable
6.2.
INCOMPATIBILITIES
Not applicable
6.3.
SHELF LIFE
Not applicable
6.4.
SPECIAL PRECAUTIONS FOR STORAGE
Not applicable
6.5.
NATURE AND CONTENTS OF CONTAINER
Not applicable
6.6.
INSTRUCTION FOR USE AND HANDLING (, AND DISPOSAL)
Not applicable
No Data Held
ADMINISTRATIVE DATA
7.
MARKETING AUTHORISATION HOLDER
Not applicable
8.
MARKETING AUTHORISATION NUMBER
Not applicable
9.
DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION
Not applicable
10.
DATE OF REVISION OF THE TEXT
Not applicable